The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Florida medical device maker Vycor Medical got the FDA’s highest risk status for a recall of its Viewsite brain access systems after the company found "an unidentified black fiber" on a device.
Vycor recalled a single lot of a single model of the Viewsite devices, which are designed to provide surgeons access to brain tissue and provide a working channel during procedures.
Shares of Intuitive Surgical (NSDQ:ISRG) came under pressure early yesterday on a negative report from hedge fund Citron Research, before rallying after Goldman Sachs boosted its price target on the stock.
Mela Sciences (NSDQ:MELA) announced an expanded 3-year manufacturing contract with long-time supplier Askion GmbH for production of the MelaFind devices.
MelaFind, the company’s flagship product, is a handheld, non-invasive melanoma detection and identification system designed to help a physician decide whether or not to biopsy a suspect patch of skin.
SurModics Inc. (NSDQ:SRDX) announced today that it will reduce its workforce by about 9 percent, starting with its executive team.
Senior VP and CFO Philip Ankeny was "included in the reduction," and his CFO responsibilities shifted to current senior director and general manager Timothy Arens on an interim basis.
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
Miramar Labs Inc. raised $35.8 million in a Series C funding round, leaving them just shy of their $36 million goal, according to an SEC filing.
The Sunnyvale, Calif.-based company’s claim to fame is miraDry, a laser-based treatment for excessive underarm sweat. The device uses microwave energy to cook sweat glands in two hour-long noninvasive doctor’s office visits.
The company plans to use the funds to begin marketing the device, according to Xconomy.
Scanning the language centers of the brain may help doctors objectively diagnose patients with autism, according to a researchers from Colombia University.
Researchers scanned the brain activity of 15 control children and 12 autistic children using functional magnetic resonance imaging (fMRI) while the patients listened to recordings of their parents speaking to them, and found that autistic children showed reduced rates of activity in the superior temporal gyrus, a part of the brain associated with sentence comprehension.
Vycor Medical Inc. (OTC:VYCO) bought up the assets of vision restoration therapy company NovaVision Inc. and its German subsidiary for $900,000.
Bohemia, N.Y.-based Vycor makes neurosurgery retraction devices. With NovaVisions’ assets, it picks up technology designed to treat vision loss from stoke or brain injury.
MassDevice Network
@MassDevice
LinkedIn
YouTube